• Exchange: SIX Swiss Ex
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Cytos Biotechnology AG

+ Add to Watchlist

CYTN:SW

0.20 CHF 0.000.00%

As of 11:32:07 ET on 12/19/2014.

Snapshot for Cytos Biotechnology AG (CYTN)

Open: 0.20 Day's Range: 0.18 - 0.20 Volume: 204,521
Previous Close: 0.20 52wk Range: 0.09 - 3.89 1-Yr Rtn: -93.44%

Stock Chart for CYTN

No chart data available.
  • CYTN:SW 0.20
  • 1D
  • 1M
  • 1Y
0.20
Interactive CYTN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CYTN

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SMI -
Earnings Per Share (CHF) (ttm) -
Est. EPS (CHF) (12/2014) -0.9150
Est. PEG Ratio -
Market Cap (M CHF) 6.11
Shares Outstanding (M) 30.53
30 Day Average Volume 790,879
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CYTN

  • Revenue
  • Net Income (M/CHF)
  • Profit Margin (%)

Company Profile & Key Executives for CYTN

Cytos Biotechnology AG develops and produces biopharmaceuticals. The Company produces vaccines that immunize the patient against disease related proteins. This instructs the immune system to produce antibodies to reverse or prevent disease progression. Cytos develops treatments for immunology and inflammation disorders, cancer and cardiovascular, nervous system, and infectious diseases.

Christian ItinChairman/CEOHarry WeltenExec VP/CFO
Frank HenneckeExec VP:Product DevDorothee KrumwiehVice President
More Company Profile & Key Executives for CYTN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil